Home
Home

Chron's Disease

Coronado Biosciences: 2013 - Year Of The Worm

Coronado Biosciences: 2013 - Year Of The Worm
Seeking Alpha

Can Johnson & Johnson Cash In on Stelara?

Can Johnson & Johnson Cash In on Stelara?
Motley Fool

Teva Phase IIa Laquinimod trail results show positive data for Chron's

Teva Phase IIa Laquinimod trail results show positive data for Chron's
Yahoo/Fly on the Wall
Submitted by admin on Thu, 03/10/2011 - 12:09

Device News

Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
Yahoo/MarketWire
Submitted by moderatora on Mon, 10/25/2010 - 11:19

Device News

New Data Show PillCam(R) SB to Be an Accurate Tool to Evaluate Patients With Crohn's Disease, Functional GI Disorders and OGIB
Yahoo/Marketwire
»

News

Astra settles with Teva on Chron's disease drug
Yahoo/AP
»

News

Celgene (analysis)
Investor's Business Daily
»

News

Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Improves Health-Related Quality of Life for Crohn's Disease Patients with Prior Exposure or Inadequate Response to Anti-TNF Therapy
Yahoo/BusinessWire
»